- Home
- KTCC vs LVTX Comparison
KTCC vs LVTX Comparison
Compare KTCC & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- LVTX
- Stock Information
- Founded
- KTCC 1969
- LVTX 2016
- Country
- KTCC United States
- LVTX Netherlands
- Employees
- KTCC N/A
- LVTX N/A
- Industry
- KTCC Electrical Products
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- KTCC Technology
- LVTX Health Care
- Exchange
- KTCC Nasdaq
- LVTX Nasdaq
- Market Cap
- KTCC 51.2M
- LVTX 43.9M
- IPO Year
- KTCC N/A
- LVTX 2021
- Fundamental
- Price
- KTCC $5.50
- LVTX $1.68
- Analyst Decision
- KTCC
- LVTX Strong Buy
- Analyst Count
- KTCC 0
- LVTX 2
- Target Price
- KTCC N/A
- LVTX $6.00
- AVG Volume (30 Days)
- KTCC 31.2K
- LVTX 36.2K
- Earning Date
- KTCC 10-29-2024
- LVTX 11-14-2024
- Dividend Yield
- KTCC N/A
- LVTX N/A
- EPS Growth
- KTCC N/A
- LVTX N/A
- EPS
- KTCC N/A
- LVTX N/A
- Revenue
- KTCC $559,396,000.00
- LVTX $7,398,000.00
- Revenue This Year
- KTCC N/A
- LVTX N/A
- Revenue Next Year
- KTCC N/A
- LVTX N/A
- P/E Ratio
- KTCC N/A
- LVTX N/A
- Revenue Growth
- KTCC N/A
- LVTX N/A
- 52 Week Low
- KTCC $3.60
- LVTX $1.13
- 52 Week High
- KTCC $6.14
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- KTCC 58.90
- LVTX 46.47
- Support Level
- KTCC $5.30
- LVTX $1.58
- Resistance Level
- KTCC $5.73
- LVTX $1.72
- Average True Range (ATR)
- KTCC 0.31
- LVTX 0.09
- MACD
- KTCC -0.02
- LVTX 0.01
- Stochastic Oscillator
- KTCC 44.03
- LVTX 43.27
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.